ACADIA Pharmaceuticals, Inc. (ACAD)
22.32
+0.06
(+0.27%)
USD |
NASDAQ |
Apr 01, 16:00
22.34
+0.02
(+0.07%)
After-Hours: 20:00
ACADIA Pharmaceuticals Research and Development Expense (TTM) : 328.80M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Insmed, Inc. | 771.09M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| Axsome Therapeutics, Inc. | 182.48M |
| Marker Therapeutics, Inc. | 11.80M |
| Merck & Co., Inc. | 12.71B |